By CAMPEP category
View another way?
- Radiotherapy-Radiobiology
2022 AM
Modeling Radiotherapy in Combination with Targeted Agents
Presented by Clemens Grassberger, PhD Massachusetts General Hospital
2022 AM
Nanoparticle Drone Models for Delivery of Immunotherapy to Boost the Abscopal Effect
Presented by Wilfred Ngwa, PhD Johns Hopkins University
2022 AM
Shifting the Paradigm in Radiation Planning From Constraint Satisfaction to True Optimization: The Role of Mathematical Biology
Presented by Jacob Scott Cleveland Clinic
2021 AM
A DNA Repair Inhibitor Targeting ATR Modulates Immune Responses to Radiotherapy
Presented by Scott Bright UT MD Anderson Cancer Center
2021 AM
Abdominal Flash Proton Irradiation Does Not Benefit the Intestine
Presented by QIXIAN ZHANG Massachusetts General Hospital
2021 AM
Analysis of Proton Inter-Track Interactions at Ultra-High Dose Rates
Presented by Shannon Thompson Queen's University Belfast
2021 AM
ATR Inhibition Suppresses DNA Damage Signaling and Sensitizes Cancer Cells to Photons and Protons
Presented by David Martinus UT MD Anderson Cancer Center
2021 AM
BEST IN PHYSICS (THERAPY): FLASH Sparing of Normal Tissue in a Proton Spread Out Bragg Peak
Presented by Michele Kim, PhD University of Pennsylvania
2021 AM
BEST IN PHYSICS (THERAPY): Radio-Immunotherapydose-Painting with Survival Boost Using Checkpoint Inhibitors
Presented by Sayeda Yasmin-Karim
2021 AM
Development of a Novel System for Preclinical Small Animal MR-Guided Radiation Experiments
Presented by Jace Grandinetti
2021 AM
DNA Repair Inhibitors Combined with Protons Increase Cell Radiosensitivity in Vitro
Presented by David Flint UT MD Anderson Cancer Center
2021 AM
Features Of TOPAS-NBio – Release 1.0
Presented by Jan Schuemann, PhD Physics Division, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
2021 AM
Improving the Efficiency of Small Animal IMRT with Submillimeter Dose Deposition Kernels and Total Variation Regularization
Presented by Xinmin Liu University of Pennsylvania
2021 AM
Investigating the Impact of Sustainable Delivery of Immunoadjuvant From Smart Radiotherapy Biomaterial in Pancreatic Cancer
Presented by Michele Moreau Dana Farber Cancer Institute
2021 AM
Measuring Oxygen Concentration at Ultra-Fast Rates During Proton FLASH Delivery Using Phosphorescence Quenching of Soluble Oxyphor Probes
Presented by Alexander Van Slyke University of Pennsylvania
2021 AM
Mechanistic Modelling of Oxygen Enhancement Ratio with DNA Damage by GMicroMC
Presented by Youfang Lai University of Texas at Arlington
2021 AM
Modeling DNA Structure with Different Chromatin Compaction in TOPAS-NBio Using Hi-C Representations
Presented by Dohyeon Yoo Physics Division, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
2021 AM
Modeling of Cellular Response After FLASH Irradiation: A Quantitative Analysis Based On the Radiolytic Oxygen Depletion Hypothesis
Presented by Hongyu Zhu Department of Radiation Oncology, Sun Yat-sen University Cancer Center
2021 AM
Modeling Radiation-Induced Oxygen Depletion and Its Effects On Normal Tissue Complications in FLASH-RT
Presented by Sunan Cui Stanford University
2021 AM
Nanoparticle-Mediated Assessment of ROS and Radiosensitization of Brain Cancer Cells for Improved Radiotherapy Outcomes
Presented by Caleb Thiegs Creighton University
2021 AM
Potential Anti-Kras Activity OfFlavonoid Derivative of Cannabis Is Enhanced by a Single Fraction of Low Doseof Radiation Therapy
Presented by Sayeda Yasmin-Karim
2021 AM
Radiodynamic Therapy for Treatment of Lung Cancer: An In-Vivo Study
Presented by Dae-myoung Yang Fox Chase Cancer Center
2021 AM
Second Generation Silica-Based Bismuth Gadolinium Nanoparticles for Tumor Dose Enhancement and Real-Time MR-Tracking
Presented by Needa Virani, PhD Brigham and Women's Hospital & Dana-Farber Cancer
2021 AM
TOPAS-NBio Simulation of Radiation Chemistry Following FLASH Irradiation Including Reactions of Biological Importance
Presented by Magdalena Grochowska University of Warsaw
2019 AM
Clinical/Biology
Presented by Billy Loo, MD Stanford University
2019 AM
FLASH Photon
Presented by Julianne Pollard-Larkin, PhD MD Anderson Cancer Center
2019 AM
FLASH Protons
Presented by Lei Dong, PhD University of Pennsylvania
2019 AM
Memorial Symposia Introduction
Presented by Lawrence Rothenberg, PhD Memorial Sloan-Kettering Cancer Center
2019 AM
Radiobiology - Biological Effects, Therapeutic Ratio, and Hypofractionated RT
Presented by Ellen Yorke, PhD Memorial Sloan-Kettering Cancer Center
2019 AM
Radioepidemiology - Genetics, Family History, and Environment - Update From the WECARE Breast Cancer Epidemiology Study
Presented by Jonine Bernstein, Memorial Sloan Kettering Cancer
2019 AM
Safety - Prevention of Errors in Radiation Oncology: Current Strengths and Opportunities
Presented by Grace Gwe-Ya Kim, PhD University of California, San Diego
2017 AM
A Research Example - Working with Jack On Hypofractionation
Presented by Mark Ritter, University of Wisconsin School of Medicine and Public Health
2017 AM
Clinical Aspects of SBRT in Abdominal Regions
Presented by Brian Kavanagh, PhD University of Colorado Health Science
2017 SCM
Clinical Outcomes Modeling and Molecular Imaging for Hypofractionated Radiotherapy
Presented by David Carlson, PhD, Yale Univ. School of Medicine
2017 AM
GMicroMC: Accelerating Microscopic Monte Carlo Simulation Using Rapid Parallel Processing Platforms
Presented by Zhen Tian, UT Southwestern Medical Ctr at Dallas
2017 SCM
Hypofractionated Radiation Therapy: Can Clinical Data Further Improve the Therapeutic Ratio?
Presented by Ellen Yorke, PhD, Memorial Sloan-Kettering Cancer Center
2017 AM
Introduction to Monte Carlo Simulations at the (sub-)cellular Scale: Concept and Current Status
Presented by Jan Schuemann, PhD Massachusetts General Hospital
2017 AM
Jack’s Early Career and Achievements
Presented by Colin Orton, PhD Wayne State University
2017 AM
Linear-Quadratic Modeling - Current Status and Where to Next?
Presented by Soren Bentzen, University of Maryland
2017 AM
Modelling Radiation Dose-Volume Tolerance Based On Data From Hypofractionated Head and Neck Retreatments
Presented by Panayiotis Mavroidis, PhD Univ North Carolina
2017 AM
Radiation Dose-Volume Effects for Liver SBRT
Presented by Moyed Miften, PhD University of Colorado School of Medicine
2017 AM
RITRACK: Monte-Carlo Simulation of Heavy Ion Track Structure and 3D Time Evolution of Radiolytic Species
Presented by Ianik Plante, NASA Johnson Space Center
2017 SCM
The Tolerance of the Nervous System to SBRT: Dogma, Data and Recommendations
Presented by Paul Medin, PhD, UT Southwestern Medical Ctr at Dallas
2017 AM
TOPAS-NBio: A Toolkit for Radiobiological Simulations
Presented by Aimee McNamara, Massachusetts General Hospital & Harvard Med. Sch.
2017 AM
Volume Effects and Reporting Standards for SBRT
Presented by Vitali Moiseenko, PhD UC San Diego
2016 AM
Are Track Structure Simulations Truly Needed for Radiobiology at the Cellular and Tissue Levels?
Presented by Robert Stewart, PhD University of Washington
2016 AM
Challenges and Opportunities for Implementing Biological Optimization in Particle Therapy
Presented by David Carlson, PhD Yale University School of Medicine
2016 AM
Clinical Significance of RBE Variations in Proton Therapy
Presented by Harald Paganetti, PhD Massachusetts General Hospital
2016 AM
Connecting Nanoscale Physics to Initial DNA Damage Through Track Structure Simulations
Presented by Jan Schuemann, PhD Massachusetts General Hospital
2016 AM
Modeling of Biological Processes - What Happens After Early Molecular Damage?
Presented by Stephen McMahon, Massachusetts General Hospital and Harvard Medical School
2016 AM
RBEs for Human Lung Cancer Cells Exposed to Protons and Heavier Ions: Implications for Clinical Use of Charged Particles in Cancer Therapy
Presented by Kathryn Held, Massachusetts General Hospital
2016 AM
Spatial Mapping of the RBE of Scanned Particle Beams
Presented by David Grosshans, The University of Texas MD Anderson Cancer Center
2015 AM
Advances in in Vivo Magnetic NanoparticleSensing
Presented by John Weaver, PhD Dartmouth-Hitchcock Medical Center
2015 AM
Beyond Radiation Induced Double Strand Breaks - a New Horizon for Radiation Therapy Research
Presented by Sha Chang, PhD UNC School of Medicine
2015 AM
Biological Treatment Planning
Presented by Colin Orton, PhD Wayne State University
2015 AM
Cranial TCP/NTCP Modeling Insights and Caveats
Presented by Issam El Naqa, PhD University of Michigan
2015 AM
Gold Nanoparticles as Radiosensitizers - What Does It Take To Go From the Bench to the Bedside?
Presented by Sunil Krishnan, The University of Texas MD Anderson Cancer Center
2015 AM
Intrinsically Radiolabeled Nanoparticles: An Emerging Paradigm
Presented by Weibo Cai, University of Wisconsin-Madison
2015 AM
Localized Radiation Can Induce Systemic Anti-Cancer Immune and Non-Immune Responses and How We Might Utilize It
Presented by Mansoor Ahmed, National Institutes of Health
2015 AM
Optic Nerve/Chiasm Hypofractionated SRS/SRT Dose Tolerance
Presented by Michael Milano, University of Rochester Medical Center
2015 AM
Overview of the Working Group On Stereotactic Body Radiation Therapy (WGSBRT)
Presented by Ellen Yorke, PhD Memorial Sloan-Kettering Cancer Center
2015 AM
Physical Bases for Gold Nanoparticle Applications in Radiation Oncology and X-Ray Imaging
Presented by Sang Hyun Cho, PhD UT MD Anderson Cancer Center
2015 AM
Radiation-Induced Long Distance Tumor Cell Migration Into and Out of the Radiation Field and Its Clinical Implication
Presented by Edward Graves, PhD Stanford University
2015 AM
Radiosurgery for Vestibular Schwannomas: Tumor Control Probability Analyses and Recommended Reporting Standards
Presented by Scott Soltys, Stanford Univ
2015 AM
Recurrent HNC Treated with SBRT: TCP-Based Outcome Estimates
Presented by David Clump, University of Pittsburgh Medical Center
2015 AM
Treatment Planning Evaluation and Optimization Should Be Biologically and Not Dose/volume Based
Presented by Joseph Deasy, PhD Memorial Sloan Kettering Cancer Center
2015 AM
Treatment Planning Evaluation and Optimization Should Be Dose/volume and Not Biologically Based
Presented by Charles Mayo, PhD Mayo Clinic
2015 AM
Unveiling Tumor Heterogeneity by Molecular Imaging
Presented by Robert Jeraj, PhD University of Wisconsin
2014 AM
Basic Radiobiology for the Radiotherapy Physicist
Presented by Colin Orton PhD
2014 AM
Radiation Biology II: Radiation Biology Principles Applied to Radiation Protection
Presented by Caridad Borras DSc
2014 AM
Radiation Biology III: Biological Optimization for Radiation Therapy
Presented by David Carlson PhD
2013 AM
Radiobiological Principles of Fractionated Radiotherapy and the Potential for Hypofractionation
Presented by Colin Orton, PhD, Wayne State University, Grosse Pointe, MI, 48230 UNITED STATES
2012 AM
Biologically Related Models for Treatment Planning
Presented by Ellen Yorke, New York, NY, 10065, United States
2012 AM
Practical Issues for Biologically Based Treatment Planning
Presented by X. Allen Li, Ph.D., Milwaukee, WI, 53226, United States
2012 AM
Second Cancers From Radiation Therapy Procedures
Presented by Stephen Kry, Houston, TX, 77030, United States
2011 AM
Late Effects From Radiation Therapy, Second Cancers and Cardiac Toxicity
Presented by Rebecca M Howell, PhD, UT MD Anderson Cancer Center, Houston, TX, 77030, United States
2011 AM
Late Effects From Radiation Therapy, Second Cancers and Cardiac Toxicity
Presented by Dr. Wayne David Newhauser, PhD, MD Anderson Cancer Ctr., Houston, TX, 77030, United States
2011 AM
Review of the Radiobiological Principles of Radiation Protection
Presented by Caridad Borras, DSc, Washington, DC, 20007, United States
2011 AM
Review of the Radiobiological Principles of Radiotherapy
Presented by Colin Orton
